These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31768750)

  • 1. Pharmacoepidemiology.
    Moore N; Blin P; Droz C
    Handb Exp Pharmacol; 2019; 260():433-451. PubMed ID: 31768750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is pharmacoepidemiology? Definition, methods, interest and clinical applications.
    Montastruc JL; Benevent J; Montastruc F; Bagheri H; Despas F; Lapeyre-Mestre M; Sommet A
    Therapie; 2019 Apr; 74(2):169-174. PubMed ID: 30389102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review.
    Franco JS; Vizcaya D
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00661. PubMed ID: 32965783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of French healthcare insurance databases in pediatric pharmacoepidemiology.
    Kaguelidou F; Sommet A; Lapeyre-Mestre M
    Therapie; 2018 Apr; 73(2):127-133. PubMed ID: 29588074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of real-world evidence in translational pharmacology research.
    Charvériat M; Darmoni SJ; Lafon V; Moore N; Bordet R; Veys J; Mouthon F;
    Fundam Clin Pharmacol; 2022 Apr; 36(2):230-236. PubMed ID: 34676579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A history of pharmacoepidemiology.
    Bégaud B
    Therapie; 2019 Apr; 74(2):175-179. PubMed ID: 30392701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of health care databases for pharmacoepidemiology.
    Takahashi Y; Nishida Y; Asai S
    Eur J Clin Pharmacol; 2012 Feb; 68(2):123-9. PubMed ID: 21808989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From a Viewpoint of Clinical Settings: Pharmacoepidemiology as Reverse Translational Research (rTR)].
    Kawakami J
    Yakugaku Zasshi; 2017; 137(6):681-683. PubMed ID: 28566573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evidence to support regulatory decision making: New or expanded medical product indications.
    Franklin JM; Liaw KL; Iyasu S; Critchlow CW; Dreyer NA
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):685-693. PubMed ID: 33675248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods in pharmacoepidemiology.
    Sommet A; Pariente A
    Therapie; 2019 Apr; 74(2):187-197. PubMed ID: 30819408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoepidemiology in older people: Purposes and future directions.
    Laroche ML; Sirois C; Reeve E; Gnjidic D; Morin L
    Therapie; 2019 Apr; 74(2):325-332. PubMed ID: 30773343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
    Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacoepidemiology: how to assess medicines in real-life setting?].
    Bezin J; Bosco-Levy P; Pariente A
    Rev Prat; 2017 Jun; 67(6):657-660. PubMed ID: 30512740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives.
    de Germay S; Berdaï D; Noize P
    Therapie; 2022; 77(2):229-240. PubMed ID: 34973825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data.
    Sinnott SJ; Bennett K; Cahir C
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1449-1455. PubMed ID: 28819675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study designs in paediatric pharmacoepidemiology.
    Verhamme K; Sturkenboom M
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():67-74. PubMed ID: 21107830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the Methods to Obtain Paediatric Drug Safety Information: Spontaneous Reporting and Healthcare Databases, Active Surveillance Programmes, Systematic Reviews and Meta-analyses.
    Gentili M; Pozzi M; Peeters G; Radice S; Carnovale C
    Curr Clin Pharmacol; 2018; 13(1):28-39. PubMed ID: 29412117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
    Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F
    BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the UK General Practice Research Database for pharmacoepidemiology.
    García Rodríguez LA; Pérez Gutthann S
    Br J Clin Pharmacol; 1998 May; 45(5):419-25. PubMed ID: 9643612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on drug safety and effectiveness using pharmacoepidemiological databases.
    Andersen M
    J Intern Med; 2014 Jun; 275(6):548-50. PubMed ID: 24635741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.